Charts Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
NYSE
04:00:02 29/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 291.50 USD | -1.66% |
|
-1.25% | +46.13% |
| 08-21 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| 08-20 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
Chart: Technical Analysis
Stock exchange
NYSE
CRL 291.50 $
-1.66%
192M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NYSE
| CRL | 291.50USD | -1.66% | 192M $ | |
CBOE
| CRL | 291.36USD | -1.66% | 7.5M $ | |
Boerse Muenchen
| RV6 | 249.85EUR | -0.81% | 4.75K € | |
Mexican S.E.
| CRL * | 4,720.00MXN | -1.97% | 61.36K $ | |
Deutsche Boerse AG
| RV6 | 250.50EUR | -1.03% | 0 € | |
Börse Stuttgart
| RV6 | 249.70EUR | -0.40% | 0 € | |
Tradegate
| RV6 | 251.60EUR | -1.10% | 0 € | |
Berne S.E.
| RV6 | 237.04CHF | -2.17% | 0 CHF |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 298.58 | 298.58 | 295.19 |
| Spread/Res. | -2.37% | -2.37% | -1.25% |
| Spread/Supp. | +13.36% | +33.29% | +41.65% |
| Support | 257.15 | 218.7 | 205.79 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CRL Stock
- Charts Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions

















